LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE was reported 54097 times

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 643 0.6055
1 INSPIRATORY CAPACITY DECREASED 97 0.3502
2 SLEEP DISORDER THERAPY 62 0.3131
3 APPENDICOLITH 90 0.2326
4 ANALGESIC THERAPY 62 0.1931
5 DRUG THERAPY 63 0.1858
6 MATERNAL EXPOSURE DURING DELIVERY 164 0.1655
7 TOXIC ANTERIOR SEGMENT SYNDROME 180 0.1650
8 INFUSION SITE DISCHARGE 221 0.1259
9 METHAEMOGLOBINAEMIA 253 0.1092
10 INFUSION SITE MASS 98 0.0902
11 INFUSION SITE URTICARIA 59 0.0881
12 CAUDA EQUINA SYNDROME 64 0.0833
13 INFUSION SITE BRUISING 179 0.0828
14 INFUSION SITE PRURITUS 255 0.0807
15 INFUSION SITE HAEMORRHAGE 241 0.0732
16 ANAESTHETIC COMPLICATION 195 0.0725
17 PROCEDURAL HYPOTENSION 54 0.0635
18 ANAESTHETIC COMPLICATION NEUROLOGICAL 56 0.0618
19 INFUSION SITE RASH 83 0.0605
20 INFUSION SITE SWELLING 374 0.0594
21 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 63 0.0593
22 INFUSION SITE DISCOMFORT 58 0.0559
23 ALLERGIC SINUSITIS 47 0.0548
24 INFUSION SITE NODULE 50 0.0520
25 DELAYED RECOVERY FROM ANAESTHESIA 48 0.0506
26 KOUNIS SYNDROME 112 0.0493
27 INFUSION SITE WARMTH 59 0.0481
28 NEPHROGENIC ANAEMIA 222 0.0479
29 HYPERPARATHYROIDISM SECONDARY 119 0.0474
30 HYPERPHOSPHATAEMIA 97 0.0451
31 INFUSION SITE IRRITATION 57 0.0444
32 DEVICE INFUSION ISSUE 108 0.0435
33 INFUSION SITE ERYTHEMA 364 0.0431
34 INFUSION SITE PAIN 547 0.0424
35 HYPERTHERMIA MALIGNANT 63 0.0423
36 INCORRECT DRUG ADMINISTRATION RATE 178 0.0418
37 INFUSION SITE EXTRAVASATION 251 0.0403
38 MULTIPLE ALLERGIES 298 0.0380
39 RETINAL VASCULITIS 45 0.0378
40 VASOPLEGIA SYNDROME 62 0.0378
41 OPHTHALMOPLEGIA 58 0.0367
42 BLOOD PHOSPHORUS INCREASED 96 0.0351
43 INSURANCE ISSUE 509 0.0333
44 CORNEAL OEDEMA 74 0.0330
45 INFUSION SITE REACTION 90 0.0301
46 SEASONAL ALLERGY 422 0.0298
47 PULSELESS ELECTRICAL ACTIVITY 123 0.0294
48 ANAPHYLACTIC SHOCK 751 0.0291
49 VENTRICULAR FIBRILLATION 308 0.0277
50 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 88 0.0265
51 REBOUND ACID HYPERSECRETION 78 0.0258
52 STRESS CARDIOMYOPATHY 146 0.0251
53 DERMATITIS CONTACT 277 0.0243
54 PARAPLEGIA 70 0.0242
55 VENTRICULAR TACHYCARDIA 384 0.0232
56 RESPIRATORY TRACT INFECTION VIRAL 54 0.0232
57 OBSTRUCTION 91 0.0228
58 LUNG OPACITY 59 0.0224
59 IRON DEFICIENCY 99 0.0220
60 END STAGE RENAL DISEASE 392 0.0215
61 PULSE ABSENT 101 0.0212
62 POOR VENOUS ACCESS 207 0.0200
63 TYPE I HYPERSENSITIVITY 70 0.0199
64 CHRONIC SINUSITIS 74 0.0197
65 EAR INFECTION 524 0.0197
66 RESPIRATORY TRACT INFECTION 509 0.0195
67 SINUSITIS 1979 0.0193
68 OTITIS MEDIA 63 0.0191
69 VENTRICULAR HYPOKINESIA 60 0.0187
70 AORTIC STENOSIS 65 0.0186
71 RETINAL ARTERY OCCLUSION 47 0.0186
72 HYPOPHOSPHATAEMIA 136 0.0184
73 CARDIOGENIC SHOCK 263 0.0183
74 GENERALISED TONIC-CLONIC SEIZURE 303 0.0183
75 ENDOPHTHALMITIS 109 0.0182
76 CANCER PAIN 46 0.0180
77 APNOEA 140 0.0180
78 STATUS EPILEPTICUS 203 0.0180
79 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 47 0.0179
80 PRODUCT DISTRIBUTION ISSUE 159 0.0171
81 SKIN ABRASION 81 0.0171
82 ARTHRITIS BACTERIAL 70 0.0170
83 UPPER RESPIRATORY TRACT INFECTION 788 0.0170
84 HAEMODYNAMIC INSTABILITY 129 0.0169
85 ANIMAL BITE 45 0.0169
86 BLOOD URIC ACID INCREASED 97 0.0168
87 LUMBAR SPINAL STENOSIS 49 0.0168
88 MYASTHENIA GRAVIS 133 0.0165
89 DEAFNESS NEUROSENSORY 54 0.0164
90 VENTRICULAR ARRHYTHMIA 60 0.0164
91 LARYNGOSPASM 44 0.0163
92 ANAPHYLACTIC REACTION 903 0.0163
93 VASCULAR DEVICE INFECTION 74 0.0163
94 RHINOVIRUS INFECTION 63 0.0162
95 BUNDLE BRANCH BLOCK LEFT 68 0.0160
96 STREPTOCOCCAL INFECTION 89 0.0160
97 PROCTALGIA 101 0.0157
98 PRODUCT ADHESION ISSUE 559 0.0156
99 HYPERCAPNIA 47 0.0156
100 ANHEDONIA 406 0.0154
101 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 79 0.0154
102 SINUS TACHYCARDIA 216 0.0152
103 SKIN INFECTION 170 0.0151
104 STRIDOR 44 0.0149
105 RENAL INJURY 442 0.0149
106 ATELECTASIS 140 0.0145
107 SPINAL OSTEOARTHRITIS 127 0.0144
108 SPINAL CORD COMPRESSION 56 0.0144
109 MULTI-ORGAN FAILURE 247 0.0143
110 TENDERNESS 148 0.0142
111 BRONCHOSPASM 202 0.0141
112 GASTROENTERITIS VIRAL 254 0.0141
113 VENTRICULAR EXTRASYSTOLES 145 0.0139
114 APPENDICITIS 130 0.0139
115 NYSTAGMUS 73 0.0137
116 BRONCHIECTASIS 92 0.0136
117 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 69 0.0136
118 MENINGITIS ASEPTIC 61 0.0136
119 FEAR 365 0.0136
120 HYPOVENTILATION 44 0.0135
121 PHARYNGITIS STREPTOCOCCAL 146 0.0135
122 SKIN LACERATION 144 0.0132
123 RESPIRATORY ACIDOSIS 52 0.0132
124 RESPIRATORY DEPRESSION 162 0.0132
125 ARTHRITIS INFECTIVE 61 0.0131
126 CARDIAC ARREST 1079 0.0131
127 PARADOXICAL DRUG REACTION 48 0.0130
128 INTERVERTEBRAL DISC DEGENERATION 120 0.0130
129 NECROTISING FASCIITIS 45 0.0128
130 TOOTH INFECTION 168 0.0127
131 SKIN NECROSIS 66 0.0127
132 UNRESPONSIVE TO STIMULI 327 0.0127
133 HYPOXIA 446 0.0127
134 SINUS BRADYCARDIA 122 0.0126
135 POST PROCEDURAL COMPLICATION 242 0.0126
136 BRADYCARDIA 662 0.0125
137 HYPERLIPIDAEMIA 149 0.0125
138 BACTERIAL INFECTION 232 0.0124
139 GASTROINTESTINAL INFECTION 111 0.0124
140 MYDRIASIS 158 0.0123
141 LIVE BIRTH 103 0.0123
142 DECUBITUS ULCER 99 0.0121
143 PROCEDURAL COMPLICATION 93 0.0121
144 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 106 0.0120
145 TROPONIN INCREASED 91 0.0119
146 BRONCHITIS 881 0.0119
147 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 204 0.0119
148 PRODUCT ADMINISTRATION INTERRUPTED 93 0.0118
149 PERIPHERAL VASCULAR DISORDER 61 0.0118
150 HORDEOLUM 51 0.0118
151 DIVERTICULUM INTESTINAL 51 0.0117
152 AUTOIMMUNE THYROIDITIS 44 0.0116
153 NEUROTOXICITY 203 0.0116
154 BREATH SOUNDS ABNORMAL 57 0.0115
155 CHRONIC KIDNEY DISEASE 878 0.0115
156 SENSORY LOSS 93 0.0115
157 NEURALGIA 280 0.0115
158 TORSADE DE POINTES 90 0.0115
159 BRAIN OEDEMA 144 0.0114
160 CIRCULATORY COLLAPSE 193 0.0113
161 MONOPLEGIA 49 0.0113
162 SINUS DISORDER 223 0.0112
163 ARTERIOSPASM CORONARY 45 0.0112
164 KIDNEY INFECTION 219 0.0111
165 RESPIRATORY SYNCYTIAL VIRUS INFECTION 97 0.0111
166 PSEUDOMONAS INFECTION 95 0.0111
167 VIRAL INFECTION 368 0.0110
168 RHINITIS ALLERGIC 49 0.0110
169 STAPHYLOCOCCAL INFECTION 363 0.0110
170 NORMAL NEWBORN 59 0.0108
171 RALES 63 0.0108
172 EYE INFECTION 122 0.0108
173 PHARYNGITIS 134 0.0108
174 MENTAL STATUS CHANGES 299 0.0108
175 HYPOAESTHESIA ORAL 162 0.0107
176 MYOCLONUS 128 0.0107
177 GLUCOSE TOLERANCE IMPAIRED 63 0.0106
178 POST PROCEDURAL INFECTION 86 0.0106
179 STAPHYLOCOCCAL SEPSIS 52 0.0105
180 VARICOSE VEIN 54 0.0104
181 WEIGHT FLUCTUATION 109 0.0104
182 PRE-EXISTING CONDITION IMPROVED 65 0.0104
183 TOOTH ABSCESS 106 0.0104
184 CANDIDA INFECTION 175 0.0104
185 HYPERVOLAEMIA 51 0.0103
186 INTERVERTEBRAL DISC DISORDER 44 0.0103
187 LEFT VENTRICULAR DYSFUNCTION 69 0.0103
188 SHOCK 235 0.0102
189 SPINAL COLUMN STENOSIS 48 0.0102
190 ATRIOVENTRICULAR BLOCK COMPLETE 68 0.0101
191 HEPARIN-INDUCED THROMBOCYTOPENIA 50 0.0101
192 FOOD POISONING 54 0.0101
193 CYSTITIS 320 0.0100
194 IMMUNE THROMBOCYTOPENIA 46 0.0100
195 INFUSION RELATED REACTION 665 0.0100
196 SUPRAVENTRICULAR TACHYCARDIA 94 0.0098
197 RENAL TUBULAR NECROSIS 96 0.0098
198 MENINGITIS 65 0.0097
199 ACUTE RESPIRATORY FAILURE 187 0.0097
200 HAEMORRHOIDS 189 0.0097
201 CONCUSSION 75 0.0097
202 GINGIVITIS 52 0.0096
203 LOCALISED INFECTION 233 0.0096
204 HYPERAESTHESIA 79 0.0096
205 ESCHERICHIA INFECTION 79 0.0096
206 LARYNGEAL OEDEMA 59 0.0096
207 BENIGN PROSTATIC HYPERPLASIA 49 0.0095
208 NERVE INJURY 105 0.0094
209 ACUTE PULMONARY OEDEMA 53 0.0094
210 RENAL FAILURE 1253 0.0094
211 JOINT EFFUSION 65 0.0094
212 CARDIOTOXICITY 84 0.0094
213 CELLULITIS 471 0.0093
214 ECCHYMOSIS 64 0.0093
215 INJURY 655 0.0093
216 ROTATOR CUFF SYNDROME 119 0.0093
217 ECONOMIC PROBLEM 140 0.0092
218 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 506 0.0092
219 GRAND MAL CONVULSION 85 0.0092
220 FOOD ALLERGY 71 0.0092
221 RIB FRACTURE 189 0.0092
222 ARTHROPOD BITE 68 0.0092
223 SCIATICA 145 0.0091
224 URINARY TRACT INFECTION 1550 0.0091
225 ORAL CANDIDIASIS 119 0.0090
226 FACIAL PARALYSIS 77 0.0090
227 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 70 0.0090
228 FEBRILE NEUTROPENIA 597 0.0090
229 IRON DEFICIENCY ANAEMIA 83 0.0090
230 HYPOTENSION 1799 0.0090
231 CYANOSIS 140 0.0089
232 HIATUS HERNIA 115 0.0089
233 FAILURE TO THRIVE 46 0.0089
234 TACHYPNOEA 120 0.0088
235 TACHYCARDIA 783 0.0088
236 IMPAIRED GASTRIC EMPTYING 120 0.0088
237 LIGAMENT SPRAIN 87 0.0088
238 PRODUCTIVE COUGH 418 0.0087
239 MUSCULOSKELETAL CHEST PAIN 135 0.0087
240 MIOSIS 70 0.0087
241 TRISMUS 45 0.0087
242 HYPERKERATOSIS 48 0.0087
243 OSTEOMYELITIS 157 0.0087
244 MUSCLE STRAIN 75 0.0087
245 FACIAL PAIN 77 0.0086
246 RETINAL HAEMORRHAGE 61 0.0086
247 COVID-19 PNEUMONIA 101 0.0085
248 LYMPHOEDEMA 59 0.0085
249 FIBROMYALGIA 206 0.0085
250 VITREOUS FLOATERS 83 0.0084
251 RENAL CYST 67 0.0084
252 SPINAL PAIN 98 0.0084
253 LIMB INJURY 227 0.0083
254 NERVE COMPRESSION 77 0.0083
255 MULTIPLE ORGAN DYSFUNCTION SYNDROME 235 0.0083
256 POSTOPERATIVE WOUND INFECTION 56 0.0083
257 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 45 0.0083
258 SKIN WARM 48 0.0082
259 DIPLOPIA 214 0.0082
260 SCAR 141 0.0082
261 EXOSTOSIS 75 0.0082
262 HAND FRACTURE 58 0.0082
263 ILLNESS 840 0.0081
264 BEHAVIOUR DISORDER 44 0.0081
265 COVID-19 1424 0.0081
266 DRUG LEVEL INCREASED 134 0.0081
267 RESPIRATORY TRACT CONGESTION 128 0.0080
268 TRICUSPID VALVE INCOMPETENCE 64 0.0080
269 CARDIOMEGALY 99 0.0080
270 FOOT FRACTURE 152 0.0080
271 UPPER-AIRWAY COUGH SYNDROME 66 0.0080
272 PNEUMOTHORAX 127 0.0080
273 DRUG TOXICITY 109 0.0080
274 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 417 0.0080
275 SPINAL COMPRESSION FRACTURE 66 0.0080
276 OSTEOPENIA 121 0.0080
277 CLOSTRIDIUM DIFFICILE COLITIS 84 0.0079
278 OXYGEN SATURATION DECREASED 445 0.0079
279 THERAPY PARTIAL RESPONDER 123 0.0079
280 ULCER 125 0.0078
281 HYPOALBUMINAEMIA 61 0.0078
282 TOXICITY TO VARIOUS AGENTS 1317 0.0078
283 SLEEP APNOEA SYNDROME 149 0.0078
284 CARDIO-RESPIRATORY ARREST 326 0.0078
285 EYELID PTOSIS 79 0.0078
286 INCONTINENCE 82 0.0077
287 RESPIRATORY DISTRESS 214 0.0077
288 WRONG PRODUCT ADMINISTERED 52 0.0077
289 ANAL INCONTINENCE 69 0.0077
290 PARAESTHESIA ORAL 110 0.0076
291 SINUS CONGESTION 103 0.0076
292 MALNUTRITION 85 0.0076
293 BODY TEMPERATURE INCREASED 155 0.0076
294 AUTOIMMUNE DISORDER 74 0.0076
295 VITAMIN D DEFICIENCY 74 0.0076
296 BLOOD PRESSURE DECREASED 504 0.0076
297 FLANK PAIN 71 0.0076
298 ORAL DISORDER 55 0.0075
299 BURSITIS 91 0.0075
300 WOUND INFECTION 82 0.0075
301 OBSTRUCTIVE AIRWAYS DISORDER 83 0.0075
302 DIVERTICULUM 53 0.0075
303 ENCEPHALOPATHY 183 0.0074
304 DYSARTHRIA 278 0.0074
305 MUSCULOSKELETAL DISCOMFORT 127 0.0074
306 INTERVERTEBRAL DISC PROTRUSION 161 0.0074
307 LUNG INFILTRATION 65 0.0074
308 GOUT 132 0.0073
309 UNEVALUABLE EVENT 556 0.0073
310 BACTERAEMIA 87 0.0073
311 SENSITIVE SKIN 54 0.0073
312 PNEUMONIA BACTERIAL 67 0.0073
313 BLOOD CALCIUM INCREASED 64 0.0073
314 CARPAL TUNNEL SYNDROME 102 0.0073
315 MOTOR DYSFUNCTION 74 0.0073
316 RESPIRATORY ARREST 200 0.0072
317 HYPERCHOLESTEROLAEMIA 70 0.0072
318 MASS 101 0.0072
319 PREMATURE DELIVERY 115 0.0072
320 ASPIRATION 79 0.0072
321 NECK PAIN 402 0.0072
322 SEPSIS 802 0.0072
323 INADEQUATE ANALGESIA 61 0.0072
324 POST-TRAUMATIC STRESS DISORDER 48 0.0072
325 SMALL INTESTINAL OBSTRUCTION 88 0.0071
326 LEUKOCYTOSIS 129 0.0071
327 OEDEMA 386 0.0071
328 JOINT INJURY 152 0.0071
329 PNEUMONIA ASPIRATION 177 0.0071
330 SEROTONIN SYNDROME 136 0.0071
331 PARALYSIS 101 0.0070
332 PULMONARY MASS 105 0.0070
333 PULMONARY OEDEMA 314 0.0070
334 CONJUNCTIVITIS 130 0.0070
335 JOINT DISLOCATION 74 0.0070
336 HEREDITARY ANGIOEDEMA 75 0.0070
337 PLEURAL EFFUSION 425 0.0070
338 MITRAL VALVE INCOMPETENCE 79 0.0070
339 RESPIRATION ABNORMAL 48 0.0070
340 IMPAIRED QUALITY OF LIFE 100 0.0069
341 FUNGAL INFECTION 230 0.0069
342 OSTEOARTHRITIS 292 0.0069
343 DELIRIUM 239 0.0069
344 ACCIDENT 82 0.0069
345 PULMONARY CONGESTION 90 0.0068
346 BRAIN FOG 106 0.0068
347 SPINAL DISORDER 64 0.0068
348 HAEMATOCRIT DECREASED 134 0.0068
349 DEPRESSED LEVEL OF CONSCIOUSNESS 267 0.0067
350 RESPIRATORY FAILURE 492 0.0067
351 PHARYNGEAL SWELLING 66 0.0067
352 EYE MOVEMENT DISORDER 46 0.0067
353 TOXIC EPIDERMAL NECROLYSIS 102 0.0067
354 JOINT RANGE OF MOTION DECREASED 90 0.0067
355 PNEUMONIA 2171 0.0067
356 RHINITIS 54 0.0067
357 POOR QUALITY SLEEP 144 0.0067
358 BLOOD ALBUMIN DECREASED 53 0.0067
359 WALKING AID USER 44 0.0067
360 ORAL PAIN 149 0.0066
361 HERPES ZOSTER 382 0.0066
362 NEPHROPATHY 62 0.0066
363 BODY HEIGHT DECREASED 71 0.0066
364 EAR PAIN 129 0.0066
365 ASCITES 194 0.0066
366 DENTAL CARIES 73 0.0066
367 CLOSTRIDIUM DIFFICILE INFECTION 144 0.0066
368 INFLUENZA 735 0.0066
369 THERAPY NON-RESPONDER 296 0.0066
370 DIVERTICULITIS 182 0.0066
371 HYPOKALAEMIA 303 0.0066
372 CONTUSION 630 0.0065
373 DISSEMINATED INTRAVASCULAR COAGULATION 92 0.0065
374 CYTOKINE RELEASE SYNDROME 131 0.0065
375 PAPULE 46 0.0065
376 UROSEPSIS 60 0.0065
377 BLOOD PRESSURE ABNORMAL 129 0.0065
378 EXTRASYSTOLES 45 0.0064
379 EMPHYSEMA 65 0.0064
380 MIGRAINE 615 0.0064
381 HYDRONEPHROSIS 48 0.0064
382 BRAIN INJURY 64 0.0064
383 BLINDNESS TRANSIENT 47 0.0064
384 BLOOD PRESSURE DIASTOLIC DECREASED 47 0.0064
385 ILEUS 79 0.0064
386 PYELONEPHRITIS 55 0.0063
387 BLADDER DISORDER 63 0.0063
388 SKIN ULCER 164 0.0063
389 SPUTUM DISCOLOURED 60 0.0063
390 OSTEOPOROSIS 260 0.0063
391 ATAXIA 75 0.0063
392 APHTHOUS ULCER 49 0.0063
393 PREMATURE BABY 190 0.0063
394 ACUTE KIDNEY INJURY 966 0.0063
395 PROCEDURAL PAIN 175 0.0063
396 POST PROCEDURAL HAEMORRHAGE 73 0.0063
397 METABOLIC ACIDOSIS 200 0.0062
398 PULMONARY HYPERTENSION 130 0.0062
399 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1124 0.0062
400 APHONIA 87 0.0062
401 BACK PAIN 1447 0.0062
402 ELECTROCARDIOGRAM QT PROLONGED 224 0.0062
403 BLOOD UREA INCREASED 104 0.0062
404 PALLOR 168 0.0062
405 DEVICE RELATED INFECTION 95 0.0062
406 SPINAL OPERATION 76 0.0062
407 HYPERTHERMIA 47 0.0062
408 ABSCESS 98 0.0061
409 NODULE 80 0.0061
410 MICTURITION URGENCY 70 0.0061
411 RENAL FAILURE CHRONIC 47 0.0061
412 NEPHROLITHIASIS 280 0.0061
413 PURPURA 54 0.0061
414 TUBULOINTERSTITIAL NEPHRITIS 114 0.0061
415 ATRIOVENTRICULAR BLOCK 47 0.0061
416 DYSPNOEA EXERTIONAL 229 0.0061
417 ANKLE FRACTURE 94 0.0061
418 SEIZURE 701 0.0061
419 OESOPHAGITIS 66 0.0060
420 LOW BIRTH WEIGHT BABY 48 0.0060
421 BONE DISORDER 110 0.0060
422 NASOPHARYNGITIS 1110 0.0060
423 ATRIAL FLUTTER 48 0.0060
424 HEART RATE DECREASED 211 0.0060
425 LOSS OF CONSCIOUSNESS 767 0.0060
426 RETINAL DETACHMENT 55 0.0060
427 BACK INJURY 65 0.0060
428 BACK DISORDER 97 0.0060
429 ARTERIOSCLEROSIS 56 0.0059
430 PRODUCT DOSE OMISSION ISSUE 1748 0.0059
431 STOMATITIS 360 0.0059
432 PAIN IN JAW 168 0.0059
433 GROIN PAIN 52 0.0059
434 SWELLING 554 0.0059
435 TOOTHACHE 107 0.0059
436 PELVIC FRACTURE 46 0.0059
437 INFECTION 854 0.0059
438 RENAL FAILURE ACUTE 250 0.0059
439 SPINAL FRACTURE 118 0.0059
440 MYOCARDIAL ISCHAEMIA 67 0.0059
441 RESPIRATORY DISORDER 176 0.0059
442 CHILLS 689 0.0059
443 HOSPICE CARE 58 0.0059
444 ATRIAL FIBRILLATION 571 0.0059
445 INABILITY TO AFFORD MEDICATION 58 0.0058
446 HEPATOMEGALY 57 0.0058
447 BLOOD MAGNESIUM DECREASED 50 0.0058
448 DIZZINESS POSTURAL 56 0.0058
449 LYMPHOCYTE COUNT DECREASED 102 0.0058
450 NEUTROPHIL COUNT INCREASED 59 0.0058
451 MOUTH ULCERATION 121 0.0057
452 GENERALISED OEDEMA 71 0.0057
453 ORAL HERPES 111 0.0057
454 ACUTE CORONARY SYNDROME 47 0.0057
455 HEAD INJURY 179 0.0057
456 GASTROOESOPHAGEAL REFLUX DISEASE 455 0.0056
457 ACIDOSIS 43 0.0056
458 BLOOD POTASSIUM DECREASED 169 0.0056
459 MUCOSAL INFLAMMATION 147 0.0056
460 DISABILITY 111 0.0056
461 HYPONATRAEMIA 316 0.0056
462 BLOOD CALCIUM DECREASED 63 0.0056
463 MUSCLE RIGIDITY 67 0.0056
464 ELECTROLYTE IMBALANCE 65 0.0056
465 HYPERTENSIVE CRISIS 62 0.0056
466 MUSCLE TIGHTNESS 90 0.0056
467 HEMIPARESIS 94 0.0055
468 CARDIOMYOPATHY 82 0.0055
469 OROPHARYNGEAL DISCOMFORT 50 0.0055
470 EJECTION FRACTION DECREASED 86 0.0055
471 TOOTH DISORDER 123 0.0055
472 PAIN 3391 0.0055
473 IRRITABLE BOWEL SYNDROME 118 0.0055
474 OROPHARYNGEAL PAIN 508 0.0055
475 HAEMATOMA 142 0.0055
476 BLOOD IRON DECREASED 65 0.0055
477 MYOSITIS 49 0.0055
478 HYPOMAGNESAEMIA 76 0.0055
479 LOWER RESPIRATORY TRACT INFECTION 248 0.0054
480 TOOTH FRACTURE 60 0.0054
481 FALL 1810 0.0054
482 URINARY INCONTINENCE 161 0.0054
483 ANGIOEDEMA 240 0.0054
484 CATARACT 323 0.0054
485 ANXIETY 1541 0.0054
486 FOOT DEFORMITY 60 0.0054
487 HAEMOPTYSIS 150 0.0054
488 APPLICATION SITE PAIN 118 0.0054
489 LYMPHADENOPATHY 189 0.0053
490 WRIST FRACTURE 64 0.0053
491 MUSCLE TWITCHING 123 0.0053
492 HYPERKALAEMIA 187 0.0053
493 PULMONARY THROMBOSIS 58 0.0053
494 COMA 253 0.0053
495 HYPOTONIA 53 0.0053
496 SUBARACHNOID HAEMORRHAGE 54 0.0053
497 APHASIA 160 0.0053
498 PYREXIA 1825 0.0053
499 UPPER LIMB FRACTURE 105 0.0053
500 ERYTHEMA MULTIFORME 49 0.0052
501 HYPERTENSION 1112 0.0052
502 LETHARGY 302 0.0052
503 ACCIDENTAL OVERDOSE 191 0.0052
504 ALTERED STATE OF CONSCIOUSNESS 113 0.0052
505 BLOOD PRESSURE INCREASED 793 0.0052
506 DRUG INTERACTION 822 0.0052
507 DISCOMFORT 316 0.0052
508 TENDONITIS 80 0.0052
509 INTRAOCULAR PRESSURE INCREASED 66 0.0052
510 COLD SWEAT 91 0.0052
511 TINNITUS 237 0.0052
512 CYST 64 0.0052
513 URINARY RETENTION 172 0.0051
514 NEUROPATHY PERIPHERAL 490 0.0051
515 PRESYNCOPE 125 0.0051
516 INTENTIONAL PRODUCT USE ISSUE 450 0.0051
517 EYE INFLAMMATION 49 0.0051
518 EMOTIONAL DISTRESS 621 0.0051
519 RENAL PAIN 54 0.0051
520 BLOOD SODIUM DECREASED 96 0.0051
521 COUGH 1428 0.0051
522 LIMB DISCOMFORT 157 0.0051
523 QUALITY OF LIFE DECREASED 68 0.0051
524 TOXIC SKIN ERUPTION 51 0.0051
525 TUMOUR LYSIS SYNDROME 44 0.0050
526 INCREASED TENDENCY TO BRUISE 46 0.0050
527 RENAL IMPAIRMENT 419 0.0050
528 FACE OEDEMA 84 0.0050
529 NASAL CONGESTION 292 0.0050
530 RED BLOOD CELL COUNT DECREASED 142 0.0050
531 RESTLESS LEGS SYNDROME 90 0.0049
532 BASAL CELL CARCINOMA 77 0.0049
533 WHEEZING 292 0.0049
534 ACUTE RESPIRATORY DISTRESS SYNDROME 87 0.0049
535 RESTLESSNESS 180 0.0049
536 SEPTIC SHOCK 214 0.0049
537 DEHYDRATION 656 0.0049
538 HYPOTHYROIDISM 157 0.0049
539 BLOOD TEST ABNORMAL 69 0.0049
540 OBESITY 78 0.0049
541 PHOTOPHOBIA 92 0.0049
542 MUSCULOSKELETAL PAIN 256 0.0049
543 BLOOD URINE PRESENT 92 0.0048
544 EXPOSURE DURING PREGNANCY 301 0.0048
545 HYPOAESTHESIA 724 0.0048
546 ROAD TRAFFIC ACCIDENT 202 0.0048
547 WHITE BLOOD CELL COUNT INCREASED 185 0.0048
548 COMPLICATION ASSOCIATED WITH DEVICE 70 0.0048
549 ARRHYTHMIA 228 0.0048
550 COAGULOPATHY 80 0.0048
551 NERVOUS SYSTEM DISORDER 149 0.0048
552 VISUAL ACUITY REDUCED 158 0.0048
553 LIVER FUNCTION TEST INCREASED 102 0.0047
554 SCRATCH 50 0.0047
555 HEADACHE 2968 0.0047
556 PRODUCT USE IN UNAPPROVED INDICATION 1172 0.0047
557 DYSURIA 174 0.0047
558 WOUND 132 0.0047
559 CONSTIPATION 1029 0.0047
560 EYE DISCHARGE 49 0.0047
561 HEART RATE INCREASED 467 0.0047
562 ANAEMIA 896 0.0047
563 LUNG DISORDER 230 0.0047
564 DERMATITIS ALLERGIC 59 0.0047
565 ABDOMINAL DISTENSION 487 0.0047
566 TOOTH EXTRACTION 58 0.0047
567 SPEECH DISORDER 244 0.0047
568 CHEST PAIN 862 0.0046
569 CHROMATURIA 105 0.0046
570 OCULAR DISCOMFORT 52 0.0046
571 CONFUSIONAL STATE 746 0.0046
572 ASTHMA 520 0.0046
573 GASTROINTESTINAL DISORDER 412 0.0046
574 HALLUCINATION, VISUAL 97 0.0046
575 ASPARTATE AMINOTRANSFERASE INCREASED 244 0.0046
576 SYNCOPE 459 0.0046
577 MUSCULAR WEAKNESS 521 0.0046
578 LOWER LIMB FRACTURE 88 0.0046
579 THROMBOSIS 368 0.0046
580 EYE PAIN 258 0.0046
581 SKIN DISCOLOURATION 210 0.0046
582 OEDEMA PERIPHERAL 557 0.0046
583 BURNING SENSATION 320 0.0046
584 MATERNAL EXPOSURE DURING PREGNANCY 406 0.0046
585 HERNIA 88 0.0045
586 PERIPHERAL SWELLING 701 0.0045
587 SWOLLEN TONGUE 142 0.0045
588 FULL BLOOD COUNT ABNORMAL 48 0.0045
589 SOMNOLENCE 910 0.0045
590 CHEST DISCOMFORT 462 0.0045
591 ACUTE MYOCARDIAL INFARCTION 133 0.0045
592 C-REACTIVE PROTEIN INCREASED 164 0.0045
593 FLUID RETENTION 229 0.0045
594 FEELING COLD 125 0.0045
595 TASTE DISORDER 91 0.0045
596 PULMONARY EMBOLISM 426 0.0045
597 IMPAIRED HEALING 147 0.0045
598 DEVICE OCCLUSION 63 0.0045
599 HEART RATE IRREGULAR 101 0.0045
600 CAESAREAN SECTION 52 0.0045
601 BLOOD CHOLESTEROL INCREASED 208 0.0045
602 DYSPHAGIA 423 0.0045
603 TENDON RUPTURE 55 0.0045
604 EPISTAXIS 333 0.0044
605 VERTIGO 271 0.0044
606 NEOPLASM 51 0.0044
607 BLISTER 249 0.0044
608 AGITATION 325 0.0044
609 ARTHRITIS 348 0.0044
610 EATING DISORDER 94 0.0044
611 GASTRITIS 116 0.0044
612 HEPATIC STEATOSIS 82 0.0044
613 CORONARY ARTERY DISEASE 133 0.0044
614 SARS-COV-2 TEST POSITIVE 58 0.0044
615 TRANSFUSION 46 0.0044
616 DRY MOUTH 356 0.0044
617 EAR DISCOMFORT 45 0.0044
618 DYSTONIA 85 0.0044
619 PERICARDIAL EFFUSION 101 0.0044
620 WEIGHT DECREASED 1218 0.0044
621 MACULAR DEGENERATION 52 0.0044
622 HAIR COLOUR CHANGES 54 0.0043
623 COLITIS 164 0.0043
624 SLEEP DISORDER 305 0.0043
625 RASH MACULO-PAPULAR 96 0.0043
626 PETECHIAE 45 0.0043
627 DYSPHONIA 252 0.0043
628 DYSKINESIA 175 0.0043
629 VOMITING 2020 0.0043
630 SKIN DISORDER 143 0.0043
631 TREMOR 710 0.0043
632 BLOOD ALKALINE PHOSPHATASE INCREASED 106 0.0043
633 SKIN LESION 117 0.0043
634 ERYTHEMA 876 0.0043
635 BLOOD PRESSURE SYSTOLIC INCREASED 83 0.0043
636 DYSPNOEA 2406 0.0042
637 PAIN IN EXTREMITY 1252 0.0042
638 INFLUENZA LIKE ILLNESS 349 0.0042
639 NEEDLE ISSUE 123 0.0042
640 RHINORRHOEA 272 0.0042
641 CHOLELITHIASIS 138 0.0042
642 GLAUCOMA 81 0.0042
643 LIP SWELLING 140 0.0042
644 ADRENAL INSUFFICIENCY 51 0.0042
645 GALLBLADDER DISORDER 75 0.0042
646 CONVULSION 240 0.0042
647 NIGHT SWEATS 135 0.0042
648 BEDRIDDEN 55 0.0042
649 NAUSEA 3311 0.0042
650 DRUG INTOLERANCE 404 0.0042
651 PERICARDITIS 70 0.0042
652 FATIGUE 3239 0.0042
653 URTICARIA 696 0.0042
654 APPLICATION SITE RASH 57 0.0041
655 BLOOD POTASSIUM INCREASED 67 0.0041
656 BLOOD PRESSURE FLUCTUATION 99 0.0041
657 CHOLECYSTITIS 49 0.0041
658 EOSINOPHILIA 72 0.0041
659 MUSCLE ATROPHY 52 0.0041
660 GINGIVAL BLEEDING 56 0.0041
661 THYROID DISORDER 63 0.0041
662 BLINDNESS 166 0.0041
663 RED BLOOD CELL SEDIMENTATION RATE INCREASED 45 0.0041
664 PRODUCT ADMINISTRATION ERROR 82 0.0041
665 MUSCULOSKELETAL STIFFNESS 355 0.0040
666 MENTAL DISORDER 176 0.0040
667 RETCHING 86 0.0040
668 HAEMATURIA 138 0.0040
669 PARAESTHESIA 634 0.0040
670 DECREASED APPETITE 932 0.0040
671 ARTHROPATHY 223 0.0040
672 INFLAMMATION 207 0.0040
673 DERMATITIS 84 0.0040
674 PERIPHERAL COLDNESS 55 0.0040
675 PNEUMONITIS 109 0.0040
676 FISTULA 45 0.0040
677 MEDICATION ERROR 222 0.0040
678 SECRETION DISCHARGE 50 0.0040
679 LUNG INFECTION 62 0.0040
680 DISORIENTATION 158 0.0040
681 SWELLING FACE 258 0.0040
682 DEEP VEIN THROMBOSIS 257 0.0040
683 SCAB 45 0.0039
684 MUSCLE SPASMS 719 0.0039
685 PRODUCT USE ISSUE 735 0.0039
686 PRODUCT AVAILABILITY ISSUE 89 0.0039
687 DYSSTASIA 114 0.0039
688 BALANCE DISORDER 337 0.0039
689 HEAD DISCOMFORT 69 0.0039
690 FEEDING DISORDER 79 0.0039
691 METASTASES TO LUNG 45 0.0039
692 BLOOD BILIRUBIN INCREASED 105 0.0039
693 ABDOMINAL PAIN 904 0.0039
694 OSTEONECROSIS OF JAW 96 0.0039
695 PHOTOSENSITIVITY REACTION 64 0.0039
696 HYPOKINESIA 56 0.0039
697 SEDATION 101 0.0039
698 APPLICATION SITE ERYTHEMA 101 0.0038
699 CHOLECYSTECTOMY 44 0.0038
700 PANCYTOPENIA 215 0.0038
701 GASTRIC ULCER 73 0.0038
702 METASTASES TO BONE 63 0.0038
703 SNEEZING 86 0.0038
704 SKIN REACTION 54 0.0038
705 MUSCLE SPASTICITY 47 0.0038
706 TRANSIENT ISCHAEMIC ATTACK 129 0.0038
707 STEVENS-JOHNSON SYNDROME 85 0.0038
708 INJECTION SITE EXTRAVASATION 47 0.0038
709 HYPERSENSITIVITY 704 0.0038
710 EYELID OEDEMA 44 0.0038
711 DIABETES MELLITUS 288 0.0038
712 GAIT INABILITY 126 0.0038
713 PRODUCT QUALITY ISSUE 510 0.0038
714 PULMONARY FIBROSIS 72 0.0037
715 DIZZINESS 1872 0.0037
716 HAEMOGLOBIN DECREASED 385 0.0037
717 HYPERSOMNIA 107 0.0037
718 ALANINE AMINOTRANSFERASE INCREASED 229 0.0037
719 PULMONARY ARTERIAL HYPERTENSION 54 0.0037
720 RECTAL HAEMORRHAGE 160 0.0037
721 HYPOPHAGIA 95 0.0037
722 COGNITIVE DISORDER 173 0.0037
723 BONE DENSITY DECREASED 116 0.0037
724 THROAT TIGHTNESS 100 0.0037
725 DEPRESSION 840 0.0037
726 GAIT DISTURBANCE 705 0.0037
727 PRODUCT DOSE OMISSION IN ERROR 104 0.0037
728 FULL BLOOD COUNT DECREASED 74 0.0037
729 HYPERHIDROSIS 473 0.0037
730 BONE PAIN 215 0.0037
731 HAIR TEXTURE ABNORMAL 49 0.0037
732 POISONING 46 0.0037
733 DRUG EFFECT LESS THAN EXPECTED 54 0.0036
734 CENTRAL NERVOUS SYSTEM LESION 50 0.0036
735 INTESTINAL OBSTRUCTION 137 0.0036
736 SURGERY 213 0.0036
737 NEUTROPHIL COUNT DECREASED 148 0.0036
738 ASTHENIA 1357 0.0036
739 HIP FRACTURE 116 0.0036
740 PRODUCT PRESCRIBING ISSUE 78 0.0036
741 IMMUNE SYSTEM DISORDER 47 0.0036
742 ARTHRALGIA 1482 0.0036
743 PREGNANCY 71 0.0035
744 PALPITATIONS 415 0.0035
745 LACRIMATION INCREASED 107 0.0035
746 ACTIVITIES OF DAILY LIVING IMPAIRED 70 0.0035
747 RASH 1538 0.0035
748 POLLAKIURIA 147 0.0035
749 DEAFNESS 92 0.0035
750 BLOOD CREATININE INCREASED 229 0.0035
751 DRUG ERUPTION 62 0.0035
752 SENSORY DISTURBANCE 56 0.0035
753 AMNESIA 227 0.0035
754 METASTASES TO CENTRAL NERVOUS SYSTEM 45 0.0035
755 HYPOCALCAEMIA 66 0.0035
756 THROAT IRRITATION 156 0.0035
757 OSTEONECROSIS 114 0.0035
758 JOINT STIFFNESS 91 0.0035
759 HALLUCINATION 260 0.0034
760 DRUG ABUSE 287 0.0034
761 PLATELET COUNT DECREASED 367 0.0034
762 MALAISE 1508 0.0034
763 SKIN CANCER 74 0.0034
764 RENAL DISORDER 160 0.0034
765 VISION BLURRED 471 0.0034
766 CARDIAC FAILURE 274 0.0034
767 INTENTIONAL DOSE OMISSION 97 0.0034
768 HYPERTHYROIDISM 49 0.0034
769 MENTAL IMPAIRMENT 82 0.0034
770 TOOTH LOSS 70 0.0034
771 INTENTIONAL PRODUCT MISUSE 295 0.0034
772 PARANOIA 58 0.0034
773 PRODUCT USE COMPLAINT 53 0.0034
774 CARDIAC FAILURE CONGESTIVE 270 0.0034
775 PRODUCT PREPARATION ERROR 69 0.0034
776 RASH PRURITIC 182 0.0034
777 PELVIC PAIN 61 0.0034
778 DRY EYE 167 0.0033
779 EYE DISORDER 110 0.0033
780 ORTHOSTATIC HYPOTENSION 58 0.0033
781 THROMBOCYTOPENIA 372 0.0033
782 INCORRECT PRODUCT ADMINISTRATION DURATION 72 0.0033
783 DIARRHOEA 2145 0.0033
784 DISTURBANCE IN ATTENTION 179 0.0033
785 DIALYSIS 47 0.0033
786 GENERAL PHYSICAL HEALTH DETERIORATION 382 0.0033
787 FLUID OVERLOAD 48 0.0033
788 OFF LABEL USE 2878 0.0033
789 BLOOD TRIGLYCERIDES INCREASED 58 0.0033
790 FEELING HOT 201 0.0033
791 FLUSHING 332 0.0033
792 MOBILITY DECREASED 234 0.0033
793 DYSPEPSIA 320 0.0032
794 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 155 0.0032
795 CONDITION AGGRAVATED 980 0.0032
796 TREATMENT FAILURE 267 0.0032
797 SYNOVITIS 58 0.0032
798 SUBDURAL HAEMATOMA 46 0.0032
799 ANGINA PECTORIS 92 0.0032
800 THIRST 57 0.0032
801 INCORRECT ROUTE OF DRUG ADMINISTRATION 114 0.0032
802 CARDIAC DISORDER 298 0.0032
803 HAEMORRHAGE 332 0.0032
804 WEIGHT INCREASED 711 0.0032
805 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 74 0.0032
806 BLOOD LACTATE DEHYDROGENASE INCREASED 50 0.0032
807 COORDINATION ABNORMAL 44 0.0032
808 HEPATIC CIRRHOSIS 59 0.0031
809 OVERDOSE 675 0.0031
810 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 221 0.0031
811 MULTIPLE FRACTURES 51 0.0031
812 HYPERGLYCAEMIA 113 0.0031
813 MYALGIA 526 0.0031
814 PRURITUS 1188 0.0031
815 INSOMNIA 822 0.0031
816 IMMUNODEFICIENCY 46 0.0031
817 LIVER DISORDER 136 0.0031
818 PHARYNGEAL OEDEMA 47 0.0031
819 JOINT SWELLING 367 0.0030
820 MEMORY IMPAIRMENT 416 0.0030
821 WHITE BLOOD CELL COUNT DECREASED 328 0.0030
822 NERVOUSNESS 158 0.0030
823 ACUTE MYELOID LEUKAEMIA 47 0.0030
824 RASH ERYTHEMATOUS 144 0.0030
825 MOVEMENT DISORDER 96 0.0030
826 NEUTROPENIA 403 0.0030
827 PANIC ATTACK 108 0.0030
828 DRUG INEFFECTIVE 3905 0.0030
829 FEELING ABNORMAL 708 0.0030
830 PSYCHOMOTOR HYPERACTIVITY 49 0.0029
831 FOETAL EXPOSURE DURING PREGNANCY 240 0.0029
832 HEPATIC FUNCTION ABNORMAL 110 0.0029
833 IMPAIRED WORK ABILITY 63 0.0029
834 RASH PAPULAR 66 0.0029
835 CEREBRAL HAEMORRHAGE 105 0.0029
836 RASH MACULAR 102 0.0029
837 CEREBRAL INFARCTION 71 0.0029
838 BONE MARROW FAILURE 59 0.0029
839 PLASMA CELL MYELOMA 113 0.0029
840 EPILEPSY 88 0.0029
841 HIP ARTHROPLASTY 44 0.0029
842 ABDOMINAL DISCOMFORT 480 0.0029
843 HAEMATEMESIS 72 0.0028
844 DELUSION 44 0.0028
845 ABDOMINAL PAIN UPPER 582 0.0028
846 GASTROINTESTINAL HAEMORRHAGE 236 0.0028
847 AGEUSIA 70 0.0028
848 VISUAL IMPAIRMENT 347 0.0028
849 PRESCRIBED OVERDOSE 54 0.0028
850 HEPATIC FAILURE 84 0.0028
851 FLATULENCE 158 0.0028
852 TRANSAMINASES INCREASED 61 0.0027
853 SYSTEMIC LUPUS ERYTHEMATOSUS 97 0.0027
854 MUSCULOSKELETAL DISORDER 52 0.0027
855 MELAENA 60 0.0027
856 CEREBROVASCULAR ACCIDENT 460 0.0027
857 HOT FLUSH 204 0.0027
858 AGRANULOCYTOSIS 50 0.0027
859 ISCHAEMIC STROKE 48 0.0027
860 THERAPY INTERRUPTED 192 0.0027
861 GLOSSODYNIA 60 0.0027
862 OCULAR HYPERAEMIA 127 0.0027
863 UPPER GASTROINTESTINAL HAEMORRHAGE 45 0.0027
864 GAMMA-GLUTAMYLTRANSFERASE INCREASED 59 0.0027
865 ECZEMA 138 0.0026
866 INTERNATIONAL NORMALISED RATIO INCREASED 75 0.0026
867 PROTEINURIA 50 0.0026
868 EMOTIONAL DISORDER 81 0.0026
869 PRODUCT PHYSICAL ISSUE 53 0.0026
870 DYSGEUSIA 194 0.0026
871 RHEUMATOID ARTHRITIS 296 0.0026
872 HYPOGLYCAEMIA 126 0.0026
873 RHABDOMYOLYSIS 108 0.0026
874 MIDDLE INSOMNIA 48 0.0026
875 MALIGNANT NEOPLASM PROGRESSION 263 0.0026
876 ADVERSE DRUG REACTION 230 0.0026
877 CRYING 93 0.0026
878 SUICIDAL IDEATION 234 0.0026
879 HYPOACUSIS 110 0.0026
880 DISEASE PROGRESSION 301 0.0025
881 FAECES DISCOLOURED 55 0.0025
882 BLOOD CREATINE PHOSPHOKINASE INCREASED 73 0.0025
883 ABDOMINAL PAIN LOWER 64 0.0025
884 THERAPEUTIC RESPONSE UNEXPECTED 113 0.0025
885 INTENTIONAL OVERDOSE 159 0.0025
886 KNEE ARTHROPLASTY 52 0.0025
887 FEELING JITTERY 47 0.0025
888 ALOPECIA 483 0.0025
889 SKIN FISSURES 48 0.0025
890 THERAPEUTIC PRODUCT EFFECT DECREASED 110 0.0025
891 NEOPLASM PROGRESSION 85 0.0024
892 BLOOD GLUCOSE DECREASED 117 0.0024
893 DEMENTIA 68 0.0024
894 EYE SWELLING 90 0.0024
895 APPLICATION SITE PRURITUS 54 0.0024
896 LACTIC ACIDOSIS 77 0.0024
897 TYPE 2 DIABETES MELLITUS 80 0.0024
898 INJECTION SITE SWELLING 182 0.0024
899 HOSPITALISATION 364 0.0024
900 PSORIATIC ARTHROPATHY 96 0.0024
901 THINKING ABNORMAL 44 0.0024
902 THERAPEUTIC RESPONSE DECREASED 143 0.0024
903 CHOKING 46 0.0024
904 PSYCHOTIC DISORDER 69 0.0023
905 GASTRIC DISORDER 79 0.0023
906 CARDIOVASCULAR DISORDER 58 0.0023
907 HAEMATOCHEZIA 126 0.0023
908 RASH GENERALISED 59 0.0023
909 SKIN EXFOLIATION 191 0.0023
910 LEUKOPENIA 113 0.0023
911 DRUG ADMINISTRATION ERROR 69 0.0022
912 WITHDRAWAL SYNDROME 94 0.0022
913 DEVICE DISLOCATION 97 0.0022
914 INJECTION SITE MASS 82 0.0022
915 THERAPEUTIC RESPONSE SHORTENED 73 0.0022
916 EYE IRRITATION 126 0.0022
917 SKIN IRRITATION 100 0.0022
918 WRONG TECHNIQUE IN DRUG USAGE PROCESS 79 0.0022
919 NEOPLASM MALIGNANT 145 0.0022
920 LABORATORY TEST ABNORMAL 64 0.0022
921 DEPRESSED MOOD 114 0.0022
922 HEPATIC ENZYME INCREASED 146 0.0021
923 PANCREATITIS 113 0.0021
924 ILL-DEFINED DISORDER 128 0.0021
925 INJECTION SITE PAIN 643 0.0021
926 TREATMENT NONCOMPLIANCE 114 0.0021
927 NIGHTMARE 72 0.0021
928 INJECTION SITE ERYTHEMA 258 0.0021
929 IRRITABILITY 125 0.0021
930 DEATH 1781 0.0021
931 EXTRAPYRAMIDAL DISORDER 51 0.0021
932 MOOD ALTERED 56 0.0021
933 INJECTION SITE PRURITUS 137 0.0020
934 FREQUENT BOWEL MOVEMENTS 55 0.0020
935 PRURITUS GENERALISED 44 0.0020
936 AGGRESSION 101 0.0020
937 FEMUR FRACTURE 61 0.0020
938 DRUG EFFECT DECREASED 106 0.0020
939 INTERSTITIAL LUNG DISEASE 94 0.0019
940 EXPIRED PRODUCT ADMINISTERED 64 0.0019
941 CONTRAINDICATED PRODUCT ADMINISTERED 57 0.0019
942 HEPATITIS 48 0.0019
943 MYOCARDIAL INFARCTION 327 0.0019
944 MULTIPLE SCLEROSIS 89 0.0019
945 JAUNDICE 50 0.0019
946 PRODUCT DOSE OMISSION 121 0.0019
947 PRODUCT PRESCRIBING ERROR 44 0.0018
948 INJECTION SITE REACTION 127 0.0018
949 EYE PRURITUS 62 0.0018
950 DRY SKIN 244 0.0018
951 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 53 0.0018
952 INJECTION SITE BRUISING 144 0.0018
953 NO ADVERSE EVENT 325 0.0018
954 LIVER INJURY 44 0.0018
955 DRUG-INDUCED LIVER INJURY 56 0.0018
956 PAIN OF SKIN 48 0.0018
957 VAGINAL HAEMORRHAGE 77 0.0018
958 DRUG EFFECT INCOMPLETE 64 0.0018
959 INCORRECT DOSE ADMINISTERED 396 0.0017
960 DEVICE ISSUE 154 0.0017
961 ADVERSE EVENT 153 0.0017
962 COMPLETED SUICIDE 138 0.0017
963 LIVER FUNCTION TEST ABNORMAL 48 0.0016
964 DRUG EXPOSURE DURING PREGNANCY 56 0.0016
965 ABNORMAL BEHAVIOUR 64 0.0016
966 BLOOD GLUCOSE INCREASED 304 0.0016
967 ACCIDENTAL EXPOSURE TO PRODUCT 165 0.0016
968 SUICIDE ATTEMPT 96 0.0016
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 306 0.0015
970 DEVICE LEAKAGE 65 0.0015
971 PRODUCT SUBSTITUTION ISSUE 81 0.0014
972 DEVICE BREAKAGE 57 0.0014
973 MULTIPLE SCLEROSIS RELAPSE 93 0.0014
974 DRUG WITHDRAWAL SYNDROME 115 0.0013
975 THERAPY CESSATION 67 0.0013
976 DISEASE RECURRENCE 62 0.0013
977 LUNG NEOPLASM MALIGNANT 51 0.0012
978 PSORIASIS 160 0.0012
979 COLITIS ULCERATIVE 54 0.0012
980 INJECTION SITE HAEMORRHAGE 96 0.0012
981 EXTRA DOSE ADMINISTERED 48 0.0012
982 DERMATITIS ATOPIC 61 0.0012
983 DRUG DEPENDENCE 182 0.0011
984 DEVICE MALFUNCTION 78 0.0011
985 ACNE 80 0.0011
986 SKIN BURNING SENSATION 70 0.0010
987 BREAST CANCER 90 0.0010
988 DRUG DOSE OMISSION 159 0.0010
989 UNDERDOSE 69 0.0009
990 DEVICE DIFFICULT TO USE 59 0.0009
991 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 55 0.0008
992 PRODUCT STORAGE ERROR 62 0.0007